نتایج جستجو برای: ifnl3

تعداد نتایج: 233  

Journal: :PloS one 2015
Steffen B Wiegand Benjamin Heidrich Simone Susser Magdalena Rogalska-Taranta Jörg Petersen Klaus H W Böker Natalia Grigorian Ralph Link Uwe Naumann Christine John Stefan Lueth Peter Malfertheiner Michael P Manns Heiner Wedemeyer Christoph Sarrazin Markus Cornberg

BACKGROUND SNPs near the interferon lambda (IFNL) 3 gene are predictors for sustained virological response (SVR) in patients with chronic hepatitis C genotype (GT) 1. In addition, a dinucleotide frame shift in ss469415590 was described, which generates IFNL4. In this study, we compared the role of IFNL4 variants with IFNL3-(rs12979860) and IFNL3-(rs8099917) on response to pegylated (PEG)-IFN an...

Journal: :PloS one 2015
Ahmad Amanzada Lars Reinhardt Dorothea Fey Elisabeth M Zeisberg Sabine Mihm

Genetic polymorphisms in the region of the interferon-λ genes (IFNL) associate with clearance of hepatitis C virus (HCV) infection. One of these polymorphisms, IFNL4 rs368234815, determines loss or gain of function of the IFNL4 gene by frameshift variation. The very same and a second one, IFNL3 rs4803217, are supposed to impact the expression of IFNL3: while IFNL4 rs368234815 is suggested to mo...

Journal: :Antiviral therapy 2015
Fuat Kurbanov Yonghak Kim Rachel Latanich Pooja Chaudhari Ramy El-Diwany Matt Knabel Abraham J Kandathil Andrew Cameron Andrea Cox Yoon-Young Jang David L Thomas Ashwin Balagopal

BACKGROUND Lambda interferons (IFNLs) have potent antiviral activity against HCV, and polymorphisms within the IFNL gene cluster near the IFNL3 gene strongly predict spontaneous- and treatment-related HCV infection outcomes. The mechanism(s) linking IFNL polymorphisms and HCV control is currently elusive. METHODS IFNL induction was studied in primary human hepatocytes (PHH) from 18 human dono...

2018
Adrian Egli Jyotshna Mandal Desiree M. Schumann Michael Roth Brad Thomas D. Lorne Tyrrell Francesco Blasi Kostantinos Kostikas Wim Boersma Branislava Milenkovic Alicia Lacoma Katharina Rentsch Gernot G. U. Rohde Renaud Louis Joachim G. Aerts Tobias Welte Antoni Torres Michael Tamm Daiana Stolz

BACKGROUND Interferon lambdas (IFNLs) have important anti-viral/bacterial and immunomodulatory functions in the respiratory tract. How do IFNLs impact COPD and its exacerbations? METHODS Five hundred twenty eight patients were recruited in a prospective observational multicentre cohort (PROMISE) study. The genetic polymorphisms (rs8099917 and rs12979860) within the IFNL3/4 gene region and cir...

2013
Janett Fischer Stephan Böhm Tobias Müller Heiko Witt Christoph Sarrazin Simone Susser Pascal Migaud Eckart Schott Graeme Stewart Annika Brodzinski Balazs Fülöp Florian van Bömmel Jacob George Thomas Berg

BACKGROUND & AIMS Genetic variations near the interferon lambda 3 gene (IFNL3, IL28B) are the most powerful predictors for sustained virologic response (SVR) in patients with chronic hepatitis C virus (HCV) infection, compared to other biochemical or histological baseline parameters. We evaluated whether the interplay of both IFNL3 polymorphisms rs12979860 and rs8099917 together with non-geneti...

2017
Shingo Nakamoto Fumio Imazeki Tatsuo Kanda Shuang Wu Masato Nakamura Shin Yasui Akinobu Tawada Rintaro Mikata Tetsuhiro Chiba Makoto Arai Osamu Yokosuka Hiroshi Shirasawa

BACKGROUND Genetic variation near the interferon lambda 3 (IFNL3) is known to be associated with response to pegylated interferon (pegIFN) and ribavirin combination therapy in patients with chronic hepatitis C virus (HCV) infection which is often accompanied by hepatic steatosis. AIMS We examined whether this genetic variation is associated with host lipids and treatment response. METHODS A...

2015
Karen Fitzmaurice Jacob Hurst Megan Dring Andri Rauch Paul J McLaren Huldrych F Günthard Clair Gardiner Paul Klenerman Garry Courtney Orla Crosbie John Crowe Liam Fanning John Hegarty Dermot Kelleher Emer Lawlor John Lee Susan McKiernan Frank Murray Suzanne Norris Cliona O'Farrelly Leila Thornton V Aubert M Battegay E Bernasconi J Böni HC Bucher C Burton-Jeangros A Calmy M Cavassini M Egger L Elzi J Fehr J Fellay H Furrer CA Fux M Gorgievski H Günthard D Haerry B Hasse HH Hirsch I Hösli C Kahlert L Kaiser O Keiser T Klimkait R Kouyos H Kovari B Ledergerber G Martinetti B Martinez de Tejada K Metzner N Müller D Nadal G Pantaleo A Rauch S Regenass M Rickenbach C Rudin F Schöni-Affolter P Schmid D Schultze J Schüpbach R Speck P Tarr A Telenti A Trkola P Vernazza R Weber S Yerly

BACKGROUND Chronic HCV infection is a leading cause of liver-related morbidity globally. The innate and adaptive immune responses are thought to be important in determining viral outcomes. Polymorphisms associated with the IFNL3 (IL28B) gene are strongly associated with spontaneous clearance and treatment outcomes. OBJECTIVE This study investigates the importance of HLA genes in the context o...

2015
Yi-Fan Lu David M. Mauger David B. Goldstein Thomas J. Urban Kevin M. Weeks Shelton S. Bradrick

Polymorphisms near the interferon lambda 3 (IFNL3) gene strongly predict clearance of hepatitis C virus (HCV) infection. We analyzed a variant (rs4803217 G/T) located within the IFNL3 mRNA 3' untranslated region (UTR); the G allele (protective allele) is associated with elevated therapeutic HCV clearance. We show that the IFNL3 3' UTR represses mRNA translation and the rs4803217 allele modulate...

2017
Alicja E. Grzegorzewska Monika K. Świderska Adrianna Mostowska Wojciech Warchoł Paweł P. Jagodziński

BACKGROUND Circulating pro-inflammatory cytokines were associated with increased relative mortality risk, while immune parameters reflecting improved T-cell function were predictors of survival in hemodialysis (HD) patients. We evaluated in the prospective study whether variants in T helper cell cytokine-associated genes are determinants of mortality in HD patients. METHODS The study was carr...

2016
Zhifeng Lin Junguo Zhang Xiaomin Ma Shuo Yang Nana Tian Xinqi Lin Shudong Zhou Li Liu Yanhui Gao

CONTEXT Polymorphisms of the interferon lambda 3 (IFNL3) gene have been proposed to be associated with drug-induced clearance of the hepatitis C virus (HCV). However, the role of IFNL3 polymorphisms in the prediction of treatment on chronic hepatitis B (CHB) patients have yielded controversial results. The aim of this study was to clarify the role of IFNL3 polymorphisms (rs12979860, rs8099917, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید